Drug Profile
Research programme: prostaglandin D synthase inhibitors - Taiho
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Taiho Pharmaceutical
- Class
- Mechanism of Action Prostaglandin synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypersensitivity; Inflammation
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Allergy in Japan (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Inflammation in Japan (PO)